Dimensional Fund Advisors’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,095
Closed -$207K 3391
2023
Q4
$207K Sell
11,095
-11,491
-51% -$102K ﹤0.01% 3189
2023
Q3
$214K Sell
22,586
-2,665
-11% -$33K ﹤0.01% 3204
2023
Q2
$361K Hold
25,251
﹤0.01% 3130
2023
Q1
$389K Buy
25,251
+391
+2% +$6.31K ﹤0.01% 3081
2022
Q4
$334 Buy
+24,860
New +$311K ﹤0.01% 3114

Other funds holding ANVS

Dimensional Fund Advisors's ANVS Position: Q1 2024 in Review

Dimensional Fund Advisors sold out of Annovis Bio (ANVS) in Q1 2024, closing a stake of 11,095 shares — an estimated $207K sold.

Dimensional Fund Advisors first reported a position in ANVS in Q4 2022 and held it in 5 quarters. The position peaked at $389K in Q1 2023. 32 funds tracked by Wall St. Rank hold ANVS as of Q1 2024.

  • Dimensional Fund Advisors reported no remaining Annovis Bio position as of Q1 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 11,095 Annovis Bio shares in Q1 2024, an estimated $207K.
  • Dimensional Fund Advisors first reported a position in Annovis Bio in Q4 2022 and held it in 5 quarters.
  • Dimensional Fund Advisors's Annovis Bio position peaked at $389K in Q1 2023.
  • 32 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2024.

Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.